Misidentification of Candida dubliniensis isolates with the VITEK MS.


Journal

Journal de mycologie medicale
ISSN: 1773-0449
Titre abrégé: J Mycol Med
Pays: France
ID NLM: 9425651

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 23 08 2020
revised: 08 12 2020
accepted: 18 12 2020
pubmed: 4 1 2021
medline: 1 10 2021
entrez: 3 1 2021
Statut: ppublish

Résumé

The phylogenetic relatedness of Candida dubliniensis and C. albicans may lead to misidentification of C. dubliniensis and underestimation of its clinical significance. We evaluated the performance of VITEK-MS in identifying C. dubliniensis isolates following growth on different culture media. Correct identification was documented in 98% of the isolates grown on blood agar media whereas only 44% were correctly identified from SDA or CHROMagar. The use of non-manufacturer validated media for identifying C. dubliniensis with VITEK-MS, may result in misidentification of these isolates as C. albicans. This finding calls for reassessing the accuracy of fungal isolates identification in local workflows using non-validated culture media.

Identifiants

pubmed: 33388671
pii: S1156-5233(20)30248-1
doi: 10.1016/j.mycmed.2020.101107
pii:
doi:

Substances chimiques

Culture Media 0
DNA, Fungal 0
Agar 9002-18-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101107

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Maya Korem (M)

Faculty of Medicine, Hebrew University of Jerusalem Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel. Electronic address: mayak@hadassah.org.il.

Matan Joel Cohen (MJ)

Clalit Health Services, Jerusalem District, affiliated with the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Ayelet Michael-Gayego (A)

Faculty of Medicine, Hebrew University of Jerusalem Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.

Dafna Castiel (D)

Faculty of Medicine, Hebrew University of Jerusalem Department of Clinical Microbiology and Infectious Diseases, Hadassah Medical Center, Jerusalem, Israel.

Marc V Assous (MV)

Clinical Microbiology laboratory, Shaare Zedek Medical Center, Affiliated with the Hebrew University Hadassah Medical School, Jerusalem, Israel.

Sharon Amit (S)

Clinical Microbiology laboratory, The Chaim Sheba Medical Center, Ramat Gan, Israel.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH